Trial Profile
A Phase 1 Clinical Study to Assess Safety and Efficacy of Oral Fingolimod (FTY720) in Children With Rett Syndrome.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Rett syndrome
- Focus Therapeutic Use
- Acronyms FINGORETT
- 14 Jun 2018 Status changed from active, no longer recruiting to completed.
- 06 Apr 2018 Planned primary completion date changed from 1 Mar 2018 to 1 May 2018.
- 05 Apr 2017 Planned End Date changed from 1 Jul 2017 to 1 Jul 2018.